BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10555612)

  • 1. Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users.
    Pallás JR; Fariñas-Alvarez C; Prieto D; Delgado-Rodríguez M
    Eur J Epidemiol; 1999 Sep; 15(8):699-704. PubMed ID: 10555612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners.
    Pallás J; Fariñas-Alvarez C; Prieto D; Llorca J; Delgado-Rodríguez M
    Epidemiol Infect; 1999 Aug; 123(1):95-102. PubMed ID: 10487645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners.
    La Torre G; Miele L; Chiaradia G; Mannocci A; Reali M; Gasbarrini G; De Vito E; Grieco A; Ricciardi W
    BMC Infect Dis; 2007 Aug; 7():100. PubMed ID: 17760979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
    J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
    Solomon SS; Srikrishnan AK; Mehta SH; Vasudevan CK; Murugavel KG; Thamburaj E; Anand S; Kumar MS; Latkin C; Solomon S; Celentano DD
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):327-32. PubMed ID: 18845962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
    BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of infection and molecular characterization of blood-borne HIV, HCV, and HBV infections in HIV-1 infected inmates in Italy: An observational cross-sectional study.
    Sanarico N; D'Amato S; Bruni R; Rovetto C; Salvi E; Di Zeo P; Chionne P; Madonna E; Pisani G; Costantino A; Equestre M; Tosti ME; Cenci A; Maggiorella MT; Sernicola L; Pontali E; Pansera A; Quattrocchi R; Carbonara S; Signorile F; Surace LA; Federzoni G; Garlassi E; Starnini G; Monarca R; Babudieri S; Rapicetta M; Pompa MG; Caraglia A; Ensoli B; Ciccaglione AR; Buttò S
    Medicine (Baltimore); 2016 Nov; 95(44):e5257. PubMed ID: 27858889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison].
    Sáiz de la Hoya P; Bedia M; Murcia J; Cebriá J; Sánchez-Payá J; Portilla J
    Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):53-7. PubMed ID: 15743573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran.
    Ramezani A; Amirmoezi R; Volk JE; Aghakhani A; Zarinfar N; McFarland W; Banifazl M; Mostafavi E; Eslamifar A; Sofian M
    AIDS Care; 2014; 26(9):1122-6. PubMed ID: 24499303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
    Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H
    J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners--NSW, 1996.
    Butler T; Spencer J; Cui J; Vickery K; Zou J; Kaldor J
    Aust N Z J Public Health; 1999 Aug; 23(4):377-84. PubMed ID: 10462860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
    Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C and B prevalence in Spanish prisons.
    Saiz de la Hoya P; Marco A; García-Guerrero J; Rivera A;
    Eur J Clin Microbiol Infect Dis; 2011 Jul; 30(7):857-62. PubMed ID: 21274586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
    Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
    Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
    Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
    Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.